Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$120.92−0.42 (-0.35%)
Close on Nov 17, 2026Market cap $5.50BP/E 59.0Yield –
Haemonetics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Haemonetics's pe ratio was 53.8× on Nov 11, 2026, against 23.8× a year earlier. Over the last 5 years it ranged from 14.9× to 147.0×, with a median of 36.3×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 53.8× | +30.4 |
| 2025 | Dec 31, 2025 | 23.4× | −9.0 |
| 2024 | Dec 31, 2024 | 32.4× | −1.9 |
| 2023 | Dec 29, 2023 | 34.3× | −13.0 |
| 2022 | Dec 30, 2022 | 47.4× | −41.0 |
| 2021 | Dec 31, 2021 | 88.4× | +31.0 |
| 2020 | Dec 31, 2020 | 57.4× | −31.0 |
| 2019 | Dec 31, 2019 | 88.4× | −161.7 |
| 2018 | Dec 31, 2018 | 250.1× | −475.9 |
| 2017 | Dec 29, 2017 | 726.0× | +661.4 |
| 2016 | Jan 29, 2016 | 64.6× | −1.2 |
| 2015 | Dec 31, 2015 | 65.8× | +0.1 |
| 2014 | Dec 31, 2014 | 65.6× | −4.6 |
| 2013 | Dec 31, 2013 | 70.2× | +30.6 |
| 2012 | Dec 31, 2012 | 39.6× | +17.5 |
| 2011 | Dec 30, 2011 | 22.2× | −3.9 |
| 2010 | Dec 31, 2010 | 26.1× | +1.8 |
| 2009 | Dec 31, 2009 | 24.3× | – |
See a number that looks wrong?